Physiomics plc update the market on a change to the composition of its board. Dr. Christophe Chassagnole will step down as a Director of the Company and as Chief Scientific Officer (CSO), effective 31 May 2024, to pursue other career opportunities. Dr. Chassagnole has worked for Physiomics since 2004 and has been a Director and board member since 2007, most recently as CSO.

It is not intended that the Company will recruit a replacement for the role of CSO as the Company continues to focus on expenditure directly linked to revenue generating positions. In his time at the Company, Dr. Chassagnole has made important contributions in the development of the Company's client offering, the publication of thought leadership and the securing of grants.